Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SamanTree Medical’s Histolog Scanner is CE-marked and, as of September 2024, FDA-cleared for intraoperative imaging of excised tissue. Clinical studies have demonstrated high sensitivity and specificity in detecting basal cell carcinoma during Mohs surgery (>80% sensitivity, up to 100% specificity), with significant time savings compared to traditional histology. The device has been evaluated in breast, prostate, lung, brain, and ENT surgeries[2][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SamanTree Medical.